Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets

Journal of Controlled Release

Volumn 160, Issue 2, 2012, Pages 200-210

  Markov, Oleg O ^a   Mironova, Nadezda L ^a   Maslov, Mikhail A ^b   Petukhov, Ivan A ^b   Morozova, Nina G ^b   Vlassov, Valentin V ^a   Zenkova, Marina A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

Author keywords

Cationic liposomes; Dendritic cells; Transfection

Indexed keywords

ANTI-TUMORS; B16 MELANOMA; BONE-MARROW; CATIONIC LIPIDS; CATIONIC LIPOSOMES; CYTOKINE PRODUCTION; DENDRITIC CELLS; EX-VIVO; IN-VITRO; IN-VIVO; LIPOFECTAMINE; LONG CHAIN HYDROCARBONS; PLASMID DNA; TRANSFECTION; TRANSFECTION EFFICIENCY;

CELLS; DERMATOLOGY; DRUG THERAPY; EFFICIENCY; HYDROCARBONS; LIPIDS; LIPOSOMES; ONCOLOGY; PATHOLOGY; RNA;

MOLECULAR BIOLOGY;

DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; LIPOFECTAMINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO GENE TRANSFER; IN VIVO STUDY; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; DNA; DRUG CARRIERS; GREEN FLUORESCENT PROTEINS; LIPOSOMES; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; POLYAMINES; RNA, MESSENGER; STEM CELLS; TRANSFECTION;

EID: 84861403305     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.11.034     Document Type: Article

References (68)

1. D.T. Le, D.M. Pardoll, and E.M. Jaffee Cellular vaccine approaches Cancer J. 16 2010 304 310
2. C.C. Norbury Drinking a lot is good for dendritic cells Immunology 117 2006 443 451
3. I.K. Poon, M.D. Hulett, and C.R. Parish Molecular mechanisms of late apoptotic/necrotic cell clearance Cell Death Differ. 17 2010 381 397
4. R. Keller Dendritic cells: their significance in health and disease Immunol. Lett. 78 2001 113 122
5. A. Sica, and V. Bronte Altered macrophage differentiation and immune dysfunction in tumor development J. Clin. Invest. 117 2007 1155 1166
6. I. Marigo, L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte Tumorinduced tolerance and immune suppression by myeloid derived suppressor cells Immunology 222 2008 162 179
7. J.M. Melief Cancer immunotherapy by dendritic cells Immunity 29 2008 372 383
8. P. Brossart, A.W. Goldrath, and E.A. Butz Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL J. Immunol. 158 1997 3270 3276
9. P. Szabolcs, H.F. Gallardo, D.H. Ciocon, M. Sadelain, and J.W. Young Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity Blood 90 1997 2160 2167
10. J.A. Medin, S.B. Liang, J.W. Hou, L.S. Kelley, D.J. Peace, and D.H. Fowler Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo Cancer Gene Ther. 12 2005 540 551
11. M. De Veerman, C. Heirman, S. Van Meirvenne, S. Devos, J. Corthals, M. Moser, and K. Thielemans Retrovirally transduced bone marrow-derived dendritic cells require CD4 + T cell help to elicit protective and therapeutic antitumor immunity J. Immunol. 162 1999 144 151
12. P. Metharom, K.A. Ellem, C. Scmidt, and M.Q. Wei Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma Hum. Gene Ther. 12 2001 2203 2213
13. H. Firat, V. Zennou, F. Garcia-Pons, F. Ginhoux, M. Cochet, O. Danos, F.A. Lemonnier, P. Langlade-Demoyen, and P. Charneau Use of a lentiviral flap vector for inductin of CTL immunity against melanoma. Perspectives for immunotherapy J. Gene Med. 4 2002 38 45
14. M.S. Al-Dosari, and X. Gao Nonviral gene delivery: principle, limitations and recent progress AAPS J. 11 2009 671 681
15. F. Andre, and L.M. Mir DNA electrotransfer: its principles and an updated review of its therapeutic applications Gene Ther. 11 2004 33 42
16. J. Ren, J. Jia, H. Zhang, L. Zhang, B. Ma, H. Jiang, L. Di, G. Song, and J. Yu Dendritic cells pulsed with α-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma Cancer Sci. 99 2008 1420 1426
17. F. Perche, T. Benvegnu, M. Berchel, L. Lebegue, C. Pichon, P.-A. Jaffrès, and P. Midoux Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA Nanomedicine 7 2011 445 453
18. W. Weecharangsan, P. Opanasopit, T. Ngawhirunpat, A. Apirakaramwong, T. Rojanarata, U. Ruktanonchai, and R.J. Lee Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells Int. J. Pharm. 348 2008 161 168
19. V.F. Van Tendeloo, P. Ponsaerts, F. Lardon, G. Nijs, M. Lenjou, C. Van Broeckhoven, D.R. Van Bockstaele, and Z.N. Berneman Highly efficient gene delivery by mRNA electroporation in human hematopoetic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 98 2001 49 56
20. M.E. Reeves, R.E. Royal, J.S. Lam, S.A. Rosenberg, and P. Hwu Retroviral transduction of human dendritic cells with a tumor-associated antigen gene Cancer Res. 56 1996 5672 5677
21. E.Y. Nikitina, J.I. Clark, J. Van Beynen, S. Chada, A.K. Virmani, D.P. Carbone, and D.I. Gabrilovich Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients Clin. Cancer Res. 7 2001 127 135
22. A. Ribas, L.H. Butterfield, B. Hu, V.B. Dissette, A.Y. Chen, A. Koh, S.N. Amarnani, J.A. Glaspy, W.H. McBride, and J.S. Economou Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells J. Immunother. 23 2000 9 66
23. W. Song, Y. Tong, H. Carpenter, H.L. Kong, and R.G. Crystal Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen Gene Ther. 7 2000 2080 2086
24. J.G. McArthur, and R.C. Mulligan Induction of protective anti-tumor immunity by gene-modified dendritic cells J. Immunother. 21 1998 41 47
25. Y. Wan, P. Emtage, Q. Zhu, R. Foley, A. Pilon, B. Roberts, and J. Gauldie Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirustransduced dendritic cells Cell. Immunol. 198 1999 131 138
26. J. Streitz, D. Tormo, D. Schweichel, and T. Tuting Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination Cancer Gene Ther. 13 2006 318 325
27. T. Murakami, N. Tokunaga, T. Waku, S. Gomi, S. Kagawa, N. Tanaka, and T. Fujiwara Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene Clin. Cancer Res. 10 2004 3771 3880
28. S.J. Antonia, N. Mirza, I. Fricke, A. Chiappori, P. Thompson, N. Williams, G. Bepler, G. Simon, W. Janssen, J.H. Lee, K. Menander, S. Chada, and D.I. Gabrilovich Combination of p53 cancer vaccine with chmotherapy in patients with extensive stage small cell lung cancer Clin. Cancer Res. 12 2006 878 887
29. M.A. Morse, T.M. Clay, A.C. Hobeika, T. Osada, S. Khan, S. Chui, D. Niedzwiecki, D. Panicali, J. Schlom, and H.K. Lyerly Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules Clin. Cancer Res. 11 2005 3017 3024
30. M. Di Nicola, C. Carlo-Stella, R. Mortarini, P. Baldassari, A. Guidetti, G.F. Gallino, M. Del Vecchio, F. Ravagnani, M. Magni, P. Chaplin, N. Cascinelli, G. Parmiani, A.M. Gianni, and A. Anichini Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cells vaccination: a Phase I trial in metastatic melanoma Clin. Cancer Res. 10 2004 5381 5390
31. M. Morille, C. Passirani, A. Vonarbourg, A. Clavreul, and J.P. Benoit Progress in developing cationic vectors for non-viral systemic gene therapy against cancer Biomaterials 29 2008 3477 3496
32. T.H. Kim, J.W. Nah, M.H. Cho, T.G. Park, and N.S. Cho Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles J. Nanosci. Nanotechnol. 6 2006 2796 2803
33. J. Chen, Z. Li, H. Huang, Y. Yang, Q. Ding, J. Mai, W. Guo, and Y. Xu Improved antigen cross-presentation by polyethyleneimine-based nanoparticles Int. J. Nanomedicine 6 2011 77 84
34. M. Bessodes, C. Dubertret, G. Jaslin, and D. Scherman Synthesis and biological properties of new glycosidic cationic lipids for DNA delivery Bioorg. Med. Chem. Lett. 10 2000 1393 1395
35. Y. Hattori, S. Kawakami, K. Nakamura, F. Yamashita, and M. Hashida Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route J. Pharmacol. Exp. Ther. 318 2006 828 834
36. Y. Lu, S. Kawakami, F. Yamashita, and M. Hashida Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes Biomaterials 28 2007 3255 3262
37. R. Suzuki, Y. Oda, N. Utoguchi, E. Namai, Y. Taira, N. Okada, N. Kadowaki, T. Kodama, K. Tachibana, and K. Maruyama A novel strategy utilizing ultrasound for antigen delivery in dendritic cellbased cancer immunotherapy J. Control. Release 133 2009 198 205
38. T. Hinz, C.J. Buchholz, T. Van Der Stappen, K. Cichutek, and U. Kalinke Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective J. Immunother. 29 2006 472 476
39. S.J. Antonia, N. Mirza, I. Fricke, A. Chiappori, P. Thompson, N. Williams, G. Bepler, G. Simon, W. Janssen, J.H. Lee, K. Menander, S. Chada, and D.I. Gabrilovich Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer Clin. Cancer Res. 12 2006 878 887
40. C. Foged, C. Arigita, A. Sundblad, W. Jiskoot, G. Storm, and S. Frokjaer Interaction of dendritic cells with antigencontaining liposomes: effect of bilayer composition Vaccine 22 2004 15 16
41. I.A. Petukhov, M.A. Maslov, N.G. Morozova, and G.A. Serebrennikova Synthesis of polycationic lipids based on cholesterol and spermine Russ. Chem. Bull. 59 2010 260 268
42. M. Fujita, X. Zhu, R. Ueda, K. Sasaki, G. Kohanbash, E.R. Kastenhuber, H.A. McDonald, G.A. Gibson, S.C. Watkins, R. Muthuswamy, P. Kalinski, and H. Okada Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells-significant roles of CXCL10 Cancer Res. 69 2009 1587 1595
43. Y.G. Wu, G.Z. Wu, L. Wang, Y.Y. Zhang, Z. Li, and D.C. Li Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo Med. Oncol. 27 2010 736 742
44. Z. Wang, Q. Hu, W. Han, Z. Hua, W. Tian, X. Huang, and S. Li Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro Int. J. Oral Maxillofac. Surg. 35 2006 544 550
45. O. Patutina, N. Mironova, N. Popova, V. Kaledin, V. Nikolin, V. Vlassov, and M. Zenkova The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy BMC Cancer 10 2010 204
46. F. Tang, and J.A. Hughes Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro Bioconjug. Chem. 10 1999 791 796
47. A. Bajaj, S. Mishra, P. Kondaiah, and S. Bhattacharya Effect of the headgroup variation on the gene transfer properties of cholesterol based cationic lipids possessing ether linkage Biochim. Biophys. Acta 1778 2008 1222 1236
48. L. Ciania, S. Ristori, A. Salvati, L. Calamai, and G. Martini DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra Biochim. Biophys. Acta 1664 2004 70 79
49. S. Gao, J. Chen, L. Dong, Z. Ding, Y.-H. Yang, and J. Zhang Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector Eur. J. Pharm. Biopharm. 60 2005 327 334
50. P. Corish, and C. Tyler-Smith Attenuation of green fluorescent protein half-life in mammalian cells Protein Eng. 12 1999 1035 1040
51. A. Van Driessche, P. Ponsaerts, D.R. Van Bockstaele, V.F. Van Tendeloo, and Z.N. Berneman Messenger RNA electroporation: an efficient tool in immunotherapy and stem cell research Folia Histochem. Cytobiol. 43 2005 213 216
52. B. Martin, M. Sainlos, A. Aissaoui, N. Oudrhiri, M. Hauchecorne, J.-P. Vigneron, J.-M. Lehn, and P. Lehn The design of cationic lipids for gene delivery Curr. Pharm. Des. 11 2005 375 394
53. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan Toxicity of cationic lipids and cationic polymers in gene delivery J. Control. Release 114 2006 100 109
54. F. Tang, and J.A. Hughes Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA Biochem. Biophys. Res. Commun. 242 1998 141 145
55. P.S. Ajmani, F. Tang, S. Krishnaswami, E.M. Meyer, C. Sumners, and J.A. Hughes Enhanced transgene expression in rat brain cell cultures with a disulfide-containing cationic lipid Neurosci. Lett. 227 1999 141 144
56. A.J. Kirby, P. Camilleri, J.B.F.N. Engberts, M.C. Feiters, R.J.M. Nolte, O. Soderman, M. Bergsma, P.C. Bell, M.L. Fielden, C.L.G. Rodriguez, P. Guedat, A. Kremer, C. McGregor, C. Perrin, G. Ronsin, and M.C.P.M.C. van Eijk Gemini surfactants: new synthetic vectors for gene transfection Angew. Chem. Int. Ed. 42 2003 1448 1457
57. M. Nouri-Shirazi, J. Banchereau, J. Fay, and K. Palucka Dendritic cell based tumor vaccines Immunol. Lett. 74 2000 5 10
58. S. Martino, I. di Girolamo, R. Tiribuzi, F. D'Angelo, A. Datti, and A. Orlacchio Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stemcells differentiating into dendritic cells J. Biomed. Biotechnol. 2009 2009 410260
59. H. Jonuleit, U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. Enk Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur. J. Immunol. 27 1997 3135 3142
60. S. Akira, T. Taga, and T. Kishimoto Interleukin-6 in biology and medicine Adv. Immunol. 54 1993 1 78
61. C. Dinarello Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist Int. Rev. Immunol. 16 1998 457 499
62. S. Sozzani, P. Allavena, G. D'Amico, W. Luini, G. Bianchi, and M. Kataura Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties J. Immunol. 161 1998 1083 1086
63. M.C. Dieu, B. Vanbervliet, A. Vicari, J.M. Bridon, E. Oldham, and S. Ait-Yahia Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites J. Exp. Med. 188 1998 373 386
64. A. Vecchi, L. Massimiliano, S. Ramponi, W. Luini, S. Bernasconi, and R. Bonecchi Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells J. Leukoc. Biol. 66 1999 489 494
65. D.F. Tough Section 19 cytokines produced by dendritic cells M.B. Lutz, N. Romani, A. Steinkasserer, Handbook of Dendritic Cells. Biology, Diseases, and Therapies 2006 WILEY-VCH Verlag GmbH & Co. KGaA Weinheim 355 362
66. A. Elouahabi, and J.-M. Ruysschaert Formation and intracellular trafficking of lipoplexes and polyplexes Mol. Ther. 11 2005 336 347
67. R. Kedmi, N. Ben-Arie, and D. Peer The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation Biomaterials 31 2010 6867 6875
68. C. Lonez, M. Vandenbranden, and J.-M. Ruysschaert Cationic liposomal lipids: from gene carriers to cell signalling Prog. Lipid Res. 47 2008 340 347